Medicover AB (LTS:0RPS) Piotroski F-Score: 7 (As of Jul. 04, 2026) — 17% Above Median


LTS:0RPS Medicover AB LTS:0RPS
89 GF Score
Price kr238.00
GF Value kr234.40
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Medicover AB Piotroski F-Score?

Medicover AB LTS:0RPS +0.42% 89 Piotroski F-Score is 7 as of Jul. 04, 2026, which is 17% above its 10-year median of 6.00. GuruFocus rates LTS:0RPS with a GF Score™ of 89/100 and a GF Value™ of kr234.40 (Fairly Valued). The stock has 5 warning signs investors should review. Among 651 Healthcare Providers & Services companies, Medicover AB ranks better than 88.94% on this metric.

Good Sign:

Piotroski F-Score is 7, indicates a very healthy situation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicover AB has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Medicover AB's Piotroski F-Score or its related term are showing as below:

LTS:0RPS' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 7

During the past 12 years, the highest Piotroski F-Score of Medicover AB was 8. The lowest was 3. And the median was 6.

Medicover AB  (LTS:0RPS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Medicover AB Piotroski F-Score Related Terms


Medicover AB Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Medicover AB's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicover AB Piotroski F-Score Chart

Medicover AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 4.00 6.00 6.00 6.00

Medicover AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 7.00 7.00 6.00 7.00

LTS:0RPS vs HCA, THC, DVA: Piotroski F-Score Comparison

For the Medical Care Facilities subindustry, Medicover AB's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicover AB Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medicover AB's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Medicover AB's Piotroski F-Score falls into.


LTS:0RPS
89GF Score
Medicover AB LTS:0RPS
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 210.347 + 214.516 + 204.588 + 238.046 = kr867 Mil.
Cash Flow from Operations was 631.04 + 1086.881 + 1089.32 + 783.076 = kr3,590 Mil.
Revenue was 6571.408 + 6508.086 + 6656.714 + 6723.464 = kr26,460 Mil.
Gross Profit was 1564.936 + 1526.914 + 1491.966 + 1585.54 = kr6,169 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(23834.536 + 25536.755 + 25733.122 + 26345.005 + 26117.243) / 5 = kr25513.3322 Mil.
Total Assets at the begining of this year (Mar25) was kr23,835 Mil.
Long-Term Debt & Capital Lease Obligation was kr11,817 Mil.
Total Current Assets was kr5,514 Mil.
Total Current Liabilities was kr7,418 Mil.
Net Income was 71.117 + -49.953 + 98.923 + 220.183 = kr340 Mil.

Revenue was 5750.353 + 5992.082 + 6393.155 + 6332.726 = kr24,468 Mil.
Gross Profit was 1240.604 + 1284.018 + 1388.366 + 1453.646 = kr5,367 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(22606.101 + 23001.411 + 23332.565 + 24594.897 + 23834.536) / 5 = kr23473.902 Mil.
Total Assets at the begining of last year (Mar24) was kr22,606 Mil.
Long-Term Debt & Capital Lease Obligation was kr10,918 Mil.
Total Current Assets was kr5,273 Mil.
Total Current Liabilities was kr6,194 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicover AB's current Net Income (TTM) was 867. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Medicover AB's current Cash Flow from Operations (TTM) was 3,590. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=867.497/23834.536
=0.03639664

ROA (Last Year)=Net Income/Total Assets (Mar24)
=340.27/22606.101
=0.01505213

Medicover AB's return on assets of this year was 0.03639664. Medicover AB's return on assets of last year was 0.01505213. ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Medicover AB's current Net Income (TTM) was 867. Medicover AB's current Cash Flow from Operations (TTM) was 3,590. ==> 3,590 > 867 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=11817.226/25513.3322
=0.46317846

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=10918.229/23473.902
=0.46512203

Medicover AB's gearing of this year was 0.46317846. Medicover AB's gearing of last year was 0.46512203. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=5513.844/7418.215
=0.74328447

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=5273.438/6193.606
=0.85143259

Medicover AB's current ratio of this year was 0.74328447. Medicover AB's current ratio of last year was 0.85143259. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Medicover AB's number of shares in issue this year was 151.973. Medicover AB's number of shares in issue last year was 150.979. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6169.356/26459.672
=0.23316071

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=5366.634/24468.316
=0.21932993

Medicover AB's gross margin of this year was 0.23316071. Medicover AB's gross margin of last year was 0.21932993. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=26459.672/23834.536
=1.11014001

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=24468.316/22606.101
=1.08237666

Medicover AB's asset turnover of this year was 1.11014001. Medicover AB's asset turnover of last year was 1.08237666. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+1+1+0+0+1+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Medicover AB has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 7 mean?
Medicover AB (LTS:0RPS) has a Piotroski F-Score of 7 as of Jul. 04, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medicover AB and its competitors. This is 17% above median its historical median of 6.00. Over the past decade, Medicover AB's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Medicover AB ranks #72 out of 651 companies in the Healthcare Providers & Services industry, placing it in the top 11.1%.
Is Medicover AB's Piotroski F-Score too high?
Medicover AB's current Piotroski F-Score of 7 is 17% above median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Medicover AB's value of 7 is 40% above this industry median. Based on the distribution chart, Medicover AB ranks #72 out of 651 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medicover AB has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medicover AB's Piotroski F-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Medicover AB ranks #72 out of 651 companies for Piotroski F-Score. This places Medicover AB in the top 11% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Medicover AB's value of 7 is 40% above this benchmark. Historically, Medicover AB's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Medicover AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medicover AB's current Piotroski F-Score of 7 is 40% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Medicover AB and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicover AB's current Piotroski F-Score is 7, which is 17% above median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicover AB stock overvalued right now?
Based on GuruFocus' analysis, Medicover AB (LTS:0RPS) is currently considered Fairly Valued. The stock's GF Value™ is kr234.40, compared to a current price of kr238.00 — trading 1.5% above its estimated fair value. The current Piotroski F-Score is 7, which is 17% above median its 10-year median of 6.00 and 40% above the Healthcare Providers & Services industry median of 5.00. Medicover AB's overall GF Score™ is 89/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Medicover AB (LTS:0RPS), the current Piotroski F-Score is 7 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicover AB (LTS:0RPS) Overvalued in 2026?

Based on GuruFocus' analysis, Medicover AB stock appears to be overvalued. The current stock price of kr238.00 is trading 1.5% above its estimated GF Value™ of kr234.40. GuruFocus considers Medicover AB to be Fairly Valued.

Key valuation signals for LTS:0RPS:

  • Piotroski F-Score: 7 (17% above median its 10-year median of 6.00)
  • GF Value™: kr234.40 vs. price of kr238.00 (1.5% above fair value)
  • GF Score™: 89/100 with 5 warning signs
  • Industry Position: 40% above the Healthcare Providers & Services median (#72 of 651)

No single metric tells the full story. See the LTS:0RPS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicover AB Business Description

Address Riddargatan 12A, P.O. Box 5283, Stockholm, SWE, 102 46
Medicover AB is an international healthcare and diagnostic services provider. It offers a broad spectrum of healthcare services via an extensive network of ambulatory clinics, hospitals, specialty-care facilities, and laboratories. Medicover offers its services through two reportable segments: Healthcare Services, which generates the maximum revenue, and Diagnostic Services. Diagnostic Services offer a broad range of laboratory testing in all clinical pathology areas, and Healthcare Services offer medical care and related services by operating on an Integrated Healthcare and Fee-For-Service model across different countries. Geographically, the company derives maximum revenue from Germany, and the rest from Poland, India, Ukraine, Romania, and other countries.
89GF Score

Get the complete analysis for LTS:0RPS

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr238.00
Price
kr234.40
GF Value